10 Top Gainers
$Ocuphire Pharma(OCUP.US)$ shares are climbing over 75%, which is an extension of a rally yesterday on clinical trial news.
$Inspira Technologies Oxy(IINN.US)$ stock is soaring more than 20% after releasing its Q3 earnings results yesterday.
$Engine Media(GAME.US)$ shares are gaining over 28% with the release of its fiscal Q4 2021 earnings report.
$Society Pass(SOPA.US)$ stock is increasing more than 26% as it recovers from an unexpected fall yesterday.
$Biolase(BIOL.US)$ shares are rising almost 26% after the Nasdaq Exchange granted it an extension to meet the market's minimum bid price.
$Synlogic(SYBX.US)$ stock is sitting over 14% higher after presenting data from a Phase 2 clinical trial.
$Pure Storage(PSTG.US)$ shares are getting a more than 13% boost thanks to its most recent earnings report.
$Spark Networks(LOV.US)$ stock is jumping over 12% on no news which could be caused by confusion with a social media blockchain crypto that shares its ticker.
$Longeveron(LGVN.US)$ shares are up more than 9% on what could be a short-squeeze of the stock.
10 Top Losers
$Nordstrom(JWN.US)$ stock is plummeting over 27% after releasing its Q3 2021 earnings report.
$Vallon Pharmaceuticals(VLON.US)$ shares are diving more than 27% following a rally on Tuesday.
$Petros Pharmaceuticals(PTPI.US)$ stock is taking an over 22% beating as it retreats after a rally yesterday.
$Gap Inc(GPS.US)$ shares are decreasing more than 20% with the release of its third-quarter earnings report.
$Outlook Therapeutics(OTLK.US)$ stock is heading over 20% lower after announcing an increase to a bought deal offering.
$iSpecimen(ISPC.US)$ shares are pulling back more than 19% after rallying for a couple of days on Covid-19 news.
$Qualigen Therapeutics(QLGN.US)$ stock is declining close to 18% after running higher on Tuesday.
$Anaplan(PLAN.US)$ shares are slipping nearly 18% with the release of its Q3 earnings report.
$Aptevo Therapeutics(APVO.US)$ stock is dropping over 15% after soaring yesterday on a clinical trial update.
$Esperion Therapeutics(ESPR.US)$ shares close out our pre-market stock movers down over 14% following an unexpected surge close to yesterday's closing bell.